John A Stalfort Iii is Director of Acumen Pharmaceuticals, Inc.. Currently has a direct ownership of 172,324 shares of ABOS, which is worth approximately $563,499. The most recent transaction as insider was on Jul 06, 2021, when has been sold 35,000 shares (Common Stock) at a price of $16.0 per share, resulting in proceeds of $560,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 172K
0% 3M change
0% 12M change
Total Value Held $563,499

John A Stalfort III Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 06 2021
BUY
Open market or private purchase
$560,000 $16.0 p/Share
35,000 Added 16.88%
172,324 Common Stock
Jul 06 2021
BUY
Conversion of derivative security
-
130,180 Added 48.66%
137,324 Common Stock

Also insider at

VRCA
Verrica Pharmaceuticals Inc. Healthcare
TSHA
Taysha Gene Therapies, Inc. Healthcare
JAS

John A Stalfort Iii

Director
West Chester, PA

Track Institutional and Insider Activities on ABOS

Follow Acumen Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABOS shares.

Notify only if

Insider Trading

Get notified when an Acumen Pharmaceuticals, Inc. insider buys or sells ABOS shares.

Notify only if

News

Receive news related to Acumen Pharmaceuticals, Inc.

Track Activities on ABOS